跳到正文

InMed Pharmaceuticals Inc.(INM)内部人交易:高管与董事近期交易

过去 18 个月,共有 6 位内部人为 InMed Pharmaceuticals Inc.(INM)报告了 158 笔 Form 4 交易(最近一笔 2026-10-27)。

日期内部人职务类型股数市值
2026-10-27Schneeberger Daniel10% 以上股东买入4$5
2026-10-27ADAR1 Capital Management, LLC10% 以上股东买入4$5
2026-10-20Schneeberger Daniel10% 以上股东买入1$1
2026-10-20ADAR1 Capital Management, LLC10% 以上股东买入1$1
2026-10-20Schneeberger Daniel10% 以上股东买入1,086$1,434
2026-10-20ADAR1 Capital Management, LLC10% 以上股东买入1,086$1,434
2026-10-15Schneeberger Daniel10% 以上股东买入564$750
2026-10-15ADAR1 Capital Management, LLC10% 以上股东买入564$750
2026-10-15Schneeberger Daniel10% 以上股东买入8,021$10,668
2026-10-15ADAR1 Capital Management, LLC10% 以上股东买入8,021$10,668
2026-10-15Schneeberger Daniel10% 以上股东买入984$1,301
2026-10-15ADAR1 Capital Management, LLC10% 以上股东买入984$1,301
2026-10-08Schneeberger Daniel10% 以上股东买入5,601$7,436
2026-10-08ADAR1 Capital Management, LLC10% 以上股东买入5,601$7,436
2026-10-08Schneeberger Daniel10% 以上股东买入3,046$4,051
2026-10-08ADAR1 Capital Management, LLC10% 以上股东买入3,046$4,051
2026-10-08Schneeberger Daniel10% 以上股东买入2,256$2,997
2026-10-08ADAR1 Capital Management, LLC10% 以上股东买入2,256$2,997
2026-10-05Schneeberger Daniel10% 以上股东买入16,431$21,850
2026-10-05ADAR1 Capital Management, LLC10% 以上股东买入16,431$21,850
2026-10-05Schneeberger Daniel10% 以上股东买入8,307$11,048
2026-10-05ADAR1 Capital Management, LLC10% 以上股东买入8,307$11,048
2026-10-05Schneeberger Daniel10% 以上股东买入18,182$24,182
2026-10-05ADAR1 Capital Management, LLC10% 以上股东买入18,182$24,182
2026-09-16Schneeberger Daniel10% 以上股东买入28,505$36,771

来源:SEC Form 4 申报文件 · 截至 2026-10-27